Question 1
A 62-year-old male ICU patient (weight 75 kg, serum creatinine 110 µmol/L) with severe MRSA hospital-acquired pneumonia is receiving IV vancomycin. According to current consensus guidelines on therapeutic drug monitoring (TDM) of vancomycin, what is the primary pharmacokinetic/pharmacodynamic (PK/PD) target index for clinical efficacy and nephrotoxicity minimization in serious MRSA infections?
Correct Answer:
Target area under the 24-hour concentration-time curve to minimum inhibitory concentration ratio (AUC24/MIC) of 400 to 600 mg·h/L (assuming MIC by broth microdilution = 1 mg/L)
Question 2
A hospital pharmacist is designing the layout for a new cleanroom suite intended for the central preparation of cytotoxic intravenous infusions in accordance with EU GMP / PIC/S Annex 1. Which configuration of airflow and pressure cascade is mandatory for the cytotoxic preparation area?
Correct Answer:
Grade A Class II Type A2 or Type B2 Biological Safety Cabinet (or negative pressure isolator) with 100% external air exhaust, located in a Grade B room under negative pressure relative to the adjacent airlocks
Question 3
Under the Swiss Health Insurance Ordinance (Art. 71a–71d KVV / OAMal), when an oncologist requests inpatient off-label reimbursement for an expensive oncology drug outside its Swissmedic-approved indication, which criterion must be fulfilled for mandatory reimbursement by the statutory health insurer (OKP)?
Correct Answer:
The therapy is expected to provide a major therapeutic benefit against a fatal or chronic severe disease, and no approved, effective, and reimbursable alternative therapy exists
Question 4
A clinical pharmacist reviews an adverse drug event submitted to the hospital Critical Incident Reporting System (CIRS): a nurse accidentally infused 100 mL of concentrated 7.45% Potassium Chloride IV solution instead of 0.9% NaCl, resulting in cardiac arrest. According to international and Swiss patient safety standards, what is the single most effective system-level error prevention strategy?
Correct Answer:
Completely remove concentrated potassium chloride vials/ampoules from all general ward floor stocks, restricting storage strictly to the central pharmacy or premixed commercial bags
Question 5
Under the Swiss Human Research Act (HFG) and Clinical Trials Ordinance (KlinV), what regulatory authorization is required before a hospital pharmacy can manufacture and release an unapproved Investigational Medicinal Product (IMP) for a Category C clinical trial?
Correct Answer:
Approval from the cantonal ethics committee (Swissethics) and a formal clinical trial authorization from Swissmedic, with batch release by a Qualified Person (FPH Spital)
Question 1
Exam overview

About this Exam

Prepare with the Fachapotheker in FPH Spital Practice Questions - Fachapotheker in FPH in Spitalpharmazie Pharmacien ne spécialiste FPH en pharmacie hospitalière Exam practice quiz. This question bank includes 100 questions covering hospital, clinical, pharmacy, patient, and swiss. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

Fachapotheker in FPH Spital Practice Questions - Fachapotheker in FPH in Spitalpharmazie Pharmacien ne spécialiste FPH en pharmacie hospitalière Exam

This practice set contains 100 questions from the matching question bank and focuses on hospital, clinical, pharmacy, patient, and swiss. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions